Cardinal Health 303, Inc. Signs Consent Decree with FDA, Agrees to Correct Manufacturing Deficiencies
The U.S. Food and Drug Administration (FDA) today announced that Cardinal Health 303 Inc. (Cardinal 303), formerly known as Alaris Medical Systems, Inc., and three of its top executives, have signed a consent decree for condemnation and permanent injunction related to their Signature Edition (SE) infusion pumps.